Blood samples sought to uncover hidden leukemia markers in seniors

NCT ID NCT07250217

Recruiting now Knowledge-focused Sponsor: Groupe Hospitalier de la Region de Mulhouse et Sud Alsace Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to find specific epigenetic markers in the blood of elderly patients with acute myeloid leukemia (AML). Researchers will analyze DNA from blood samples of 30 AML patients and compare them to samples from healthy older adults undergoing heart surgery. The goal is to better understand the disease, not to test a treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE MYELOBLASTIC LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute myeloid leukemia disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE MYELOBLASTIC LEUKEMIA

Contacts and locations

Locations

GHRMSA
RECRUITING

Mulhouse, 68100, France
Groupe Hospitalier de la Région de Mulhouse et Sud Alsace
RECRUITING

Mulhouse, Alsace, 68100, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.